L V Prasad Eye Institute ranked among the Top 10 Global Eye Research Institutions

 

Hyderabad , March 31 : L V Prasad Eye Institute (LVPEI) has been ranked among the Top 10 global eye health institutions for its research output by the SCImago rankings agency. In the SCImago Institutions Rankings 2023, LVPEI is ranked eighth in the world (ranked second in Asia) in the Ophthalmology (health) category, making it the only eye health institution from India to be listed among the top ten global eye research institutions.
The SCImago ranking agency, a Spanish global ranking organization evaluates institutions worldwide based on their research output. The ranking is calculated by building a ‘composite indicator’ that combines and standardizes the quality and quantity of research publications, innovation (patents and patent citations) and the societal impact of research output (the social media conversations around published research). These composite values are calculated by looking at data from a variety of research and web analytics datasets. Last year, SCImago ranked institutions by speciality for the first time, and LVPEI featured in that top ten list too. They looked at five years of data to produce the rankings for 2023. “Research and innovation have been integral to LVPEI from its inception. SCImago Institutes Rankings is among the most comprehensive rankings of worldwide universities and research institutions. It is very encouraging to be ranked as one of the top 10 global eye research institutions. Being the first Indian eye care institution to feature on this list is a matter of pride and a major milestone for Indian eye and medical research,” says Dr Gullapalli N Rao, Founder Chair of L V Prasad Eye Institute.
“Another unique achievement,” says Dr Prashant Garg, Executive Chair of L V Prasad Eye Institute, “Is the fact that LVPEI is the youngest, standalone eye institute in the world to make it to the top 10, sharing the honour with organizations and universities whose history dates back to over 200 years.”
The top 10 global eye research institutions in the Ophthalmology (Health) category:
1. Moorfields Eye Hospital NHS Trust, London, UK
2. Johns Hopkins Medicine, Baltimore, USA
3. Singapore National Eye Centre, Singapore
4. University of Miami Health System, Florida, USA
5. Singapore Eye Research Institute, Singapore
6. UCLA Health System, California, USA
7. National Institutes of Health, Maryland, USA
8. L V Prasad Eye Institute, India
9. U S Department of Health & Human Services, Washington DC, USA
10. Institut National de la Sante et de la Recherche Medicale, Paris, France
Click here to view the complete listing:
www.scimagoir.com/rankings.php?area=2731&ranking=Overall&sector=Health
Established in 1987, L V Prasad Eye Institute (LVPEI), a World Health Organization Collaborating Centre for Prevention of Blindness, is a comprehensive eye health facility. It has served over 34.14 million (3 crores 41 lakh people), with more than 50 per cent entirely free of cost, irrespective of the complexity of care needed. The Prof Brien Holden Eye Research Centre at LVPEI, a Centre of Excellence, focuses on all the components of ocular research, from basic science to clinical to translational to public health and vision rehabilitation research. LVPEI also works in active collaboration with many global and national institutes. LVPEI clinicians and scientists work at the cutting edge of eye research. Their work ranges from investigating the genetic and molecular basis of eye diseases to arriving at creative modes of managing vision-threatening conditions. They are also involved in several clinical trials that evaluate the safety and efficacy of novel drugs and devices. To date, over 5000 publications have been published by the Institute. For the past two consecutive years, several researchers from LVPEI have been ranked among the top 2 per cent of global eye researchers by the Sanford University study. The research work at LVPEI is funded through competitive grants and philanthropic donations.
This story has been provided by NewsVoir. ANI will not be responsible in any way for the content of this article.